Abstract
Abnormalities of coagulation have been reported in patients with thyroid dysfunction, although there is no clear information to explain the mechanism behind such irregularities. We are presenting a case of subclinical hypothyroidism that came with coagulation disturbance (hypocoagulation). Her symptoms resolved with leothyroxin in 4 weeks. Further studies are needed to clear the pathogenesis of the coagulation disturbance in such setting. The article also outlines some patents on hypothyroidism and hyperthyroidism.
Keywords: Hemostasis, hypercoagulability hypocoagulability, subclinical thyroid dysfunction, thyroid dysfunction, hypothyroidism, Graves’ disease, vitamin-mineral complexes, levothyroxine, Willebrand factor
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Volume: 6 Issue: 2
Author(s): Parvaneh Ehsanzadeh-Cheemeh, Michelle Thompson and Michal Miller
Affiliation:
Keywords: Hemostasis, hypercoagulability hypocoagulability, subclinical thyroid dysfunction, thyroid dysfunction, hypothyroidism, Graves’ disease, vitamin-mineral complexes, levothyroxine, Willebrand factor
Abstract: Abnormalities of coagulation have been reported in patients with thyroid dysfunction, although there is no clear information to explain the mechanism behind such irregularities. We are presenting a case of subclinical hypothyroidism that came with coagulation disturbance (hypocoagulation). Her symptoms resolved with leothyroxin in 4 weeks. Further studies are needed to clear the pathogenesis of the coagulation disturbance in such setting. The article also outlines some patents on hypothyroidism and hyperthyroidism.
Export Options
About this article
Cite this article as:
Ehsanzadeh-Cheemeh Parvaneh, Thompson Michelle and Miller Michal, Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2012; 6 (2) . https://dx.doi.org/10.2174/187221412800604590
DOI https://dx.doi.org/10.2174/187221412800604590 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Thyroid Hormone-Induced Angiogenesis
Current Cardiology Reviews Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Iodine in Mammary and Prostate Pathologies
Current Chemical Biology Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Review of Endocrine Manifestations of Antiphospholid Syndrome
Current Rheumatology Reviews Assessment of Thyroid Disorders and Autoimmunity in Patients with Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets An Overview of Partial Synthesis and Transformations of Secosteroids
Current Organic Chemistry Neuroprotective Effects of Drug-Induced Therapeutic Hypothermia in Central Nervous System Diseases
Current Drug Targets Histone Acetylation in Neurodevelopment
Current Pharmaceutical Design Tumor-related Molecular Regulatory Mechanisms of Long Non-coding RNA RMST: Recent Evidence
Mini-Reviews in Medicinal Chemistry Metabolism in Patients with Rheumatoid Arthritis: Resting Energy Expenditure, Physical Activity and Diet-Induced Thermogenesis. Invited Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Melatonin Treatment Combined with TGF-β Silencing Inhibits Epithelial- Mesenchymal Transition in CF41 Canine Mammary Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry Polyphenols and Aging
Current Aging Science Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Regulation of Drug Metabolism and Transporters
Current Drug Metabolism Patent Selections:
Current Biomarkers (Discontinued)